Single PSA test may predict long-term cancer risk

Men with a PSA of less than one in midlife may 'consider cessation of further screening', authors say

Baseline PSA levels in midlife are associated with the subsequent risk of clinically significant prostate cancer, according to a large US study.


A single test taken in men, aged 55-60, predicts the long-term diagnosis of prostate cancer, the researchers have find in a secondary analysis of a large clinical trial.

Lead author Dr Evan Kovac, of Montefiore Medical Center, New York City, US, says the study suggests that men with a PSA less than one may “consider cessation of further screening as their long-term risk of lethal prostate